Clinical Trials Logo

Clinical Trial Summary

A hip or knee prosthesis can be cemented or not. The team of orthopedic surgeons from the CCOM (Centre de Chirurgie Orthopédique et de la Main) has been cementing all hip and knee prosthesis poses for many years using gentamycin cement as recommended by the French Society of Orthopedic Surgery. and trauma (SOFCOT) (1). Data obtained from the Norwegian Register of Hip Prostheses show that the best survival curve for these prostheses is found for prostheses cemented with gentamycin cement (all causes combined). Independently of the risk of aseptic loosening, infection on the prosthesis is the second complication of arthroplasty. The defense mechanism against pathogens in contact with an implant is the formation of a biofilm. Biofilm bacteria are metabolically inactive and characterized by stationary growth. Due to their slower replication, bacteria in biofilm are up to 1000 times more resistant to antibiotics. Therefore, the optimization of local antibiotic prophylaxis is essential.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06183606
Study type Observational
Source University Hospital, Strasbourg, France
Contact Jeannot GAUDIAS, MD
Phone 33 3 68 76 50 62
Email jeannot.gaudias@chru-strasbourg.fr
Status Recruiting
Phase
Start date June 14, 2019
Completion date December 2023

See also
  Status Clinical Trial Phase
Recruiting NCT01874379 - 'M'-Technique, Guided Imagery, or Standard of Care on Anxiety and Pain Pre- & Post-operatively in Elective Joint Replacement Patients N/A